Drug Profile
CDFR 0111
Alternative Names: CDFR0111; Esomeprazole/naproxen - CTCBIOLatest Information Update: 28 Apr 2018
Price :
$50
*
At a glance
- Originator CTCBIO
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Anti-inflammatories; Antirheumatics; Naphthaleneacetic acids; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Prostaglandin synthase inhibitors; Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Connective tissue disorders; Musculoskeletal disorders
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for phase-I development in Connective-tissue-disorders(In volunteers) in South Korea
- 28 Apr 2018 No recent reports of development identified for phase-I development in Musculoskeletal-disorders(In volunteers) in South Korea